Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
153.6 USD | +3.38% | +18.58% | -14.85% |
23/04 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
23/04 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
Evolution of the average Target Price on BeiGene, Ltd.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering BeiGene, Ltd.
Bernstein | |
Nomura | |
Citigroup | |
Macquarie | |
Morgan Stanley | |
Jefferies & Co. | |
JPMorgan Chase | |
Cowen | |
SVB Securities LLC | |
Guggenheim | |
CMB International | |
SVB Leerink | |
Goldman Sachs | |
HSBC | |
China Renaissance | |
CLSA |
EPS Revisions
- Stock Market
- Equities
- BGNE Stock
- Consensus BeiGene, Ltd.